LLY
Valuation Healthcare · Drug Manufacturers - General Data as of 2025-12-31P/E Ratio · Metrics
P/E Ratio
36.36
PEG Ratio
0.25
Dividend Yield
-
Gross Margin
85.05%
Net Margin
34.40%
Revenue CAGR 3Y
38.24%
ROE
100.03%
ROA
23.60%
Buyback Yield
0.09%
Current Ratio
1.58
Magic Earn Yield
3.29%
Altman Z-Score
7.67
Fair Value River
Score
Valuation 47
Profitability 87
Growth 100
Health 76
Yield 1